This case reports on a 53-year-old male patient with primary refractory high-grade B-cell lymphoma, who was hospitalized to undergo Chimeric Antigen Receptor (CAR) T-cell therapy. [pdf-embedder url="https://perfusfind.com/wp-content/uploads/2021/07/CoW_33_2021_E_web_compressed.pdf"]
Read MoreTags Archives: Chimeric Antigen Receptor T-Cell Therapy
- Home
- Chimeric Antigen Receptor T-Cell Therapy
Search
Collaborations: Luc Puis – TransplantNews – Dr. Oleksandr Babliak – Mohamed Gibreel – Prof. Elio Carvalho – Mohammed Zidan – Dr. Sam Zeraatian – Pierluigi Incarnato – The echo Lady – Sedat Gündöner – Prof. Daniel Tobler – Maria Ludmila Setti – Dr. Mario Finazzo – Mastersofultrasound – Jerry W. Jones – Omayyah Dar Odeh – Pediatricecho – Salman Butt
Recent Posts
- ECMO cases, when to say no – Nov 23
- Mock Circulatory Loop With Autoregulated Renal Circulation Based on Perfusion Pressure for Circulatory Support Devices Evaluation
- Neurocognitive dysfunction among patients undergoing coronary artery bypass surgery—A prospective study
- Exploring electrophysiology as a biomarker for human red blood cell monitoring in extracorporeal membrane oxygenation
- Coronary sinus lactate at reperfusion: A predictor of atrial fibrillation after coronary artery bypass grafting
We use cookies to provide you with the best possible user experience. By continuing to use our site, you agree to their use. Learn more

